+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bursitis Treatment Market - Global Forecast 2026-2032- Product Image
Bursitis Treatment Market - Global Forecast 2026-2032- Product Image
New

Bursitis Treatment Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 197 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977993
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bursitis Treatment Market is evolving rapidly, driven by clinical innovation, patient-centered care, and renewed focus on supply chain resilience. Senior healthcare leaders, manufacturers, and payers must adapt to shifting clinical practices and new reimbursement demands to manage costs and patient expectations across global health systems.

Market Snapshot: Bursitis Treatment Market Overview

The bursitis treatment market grew from USD 1.59 billion in 2025 to USD 1.73 billion in 2026 and is forecasted to reach USD 3.15 billion by 2032, sustaining a CAGR of 10.23%. This robust expansion reflects advancements in biologics, regenerative therapies, and digital health tools that are reshaping care delivery and fueling adoption worldwide.

Scope & Segmentation

  • Treatment Approaches: Conservative home care, pharmacologic options, injectable therapies, image-guided procedures, structured rehabilitation, surgical interventions.
  • Product Categories: Antibiotics, biologics, corticosteroids, nonsteroidal anti-inflammatory drugs.
  • Anatomical Sites: Elbow, heel, hip, knee, shoulder, reflecting nuanced procedural techniques and recovery pathways for each area.
  • End Users: Ambulatory surgical centers, home care, hospitals, orthopedic clinics, sports medicine centers, each with distinct care capacities and patient requirements.
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific—each with unique regulatory environments, healthcare infrastructure, and adoption pace.
  • Emerging Technologies: Biologics, regenerative medicine, digital health platforms, remote monitoring, minimally invasive delivery systems.

Bursitis Treatment Market: Key Takeaways

  • The rising demand for minimally invasive and durable solutions is fostering the adoption of technologically advanced therapies and integrated diagnostic workflows.
  • Digital health tools, such as teleconsultations and remote rehabilitation, are improving patient engagement, supporting access in underserved regions, and enabling data-driven decision making.
  • Stakeholders are responding to evolving payer requirements by generating practical, real-world evidence and developing outcome registries that demonstrate functional benefits and long-term value.
  • Bursitis care increasingly relies on coordinated multidisciplinary teams, integrating orthopedists, physiotherapists, and outpatient procedural experts to ensure optimal patient outcomes.
  • The adoption and design of novel therapies are highly influenced by regional healthcare infrastructure, patient demographics, and local reimbursement practices, making market-specific strategies critical.

Tariff Impact on Supply Chain and Pricing Dynamics

United States tariff adjustments enacted in 2025 have introduced added complexity for manufacturers, distributors, and healthcare providers. These changes affect procurement of devices, injectables, and pharmaceutical ingredients, prompting firms to revisit sourcing strategies and inventory management. Supply chain leaders are increasing emphasis on nearshoring, buffer stock practices, and cost-efficient formulations to maintain consistent patient access and manage price fluctuations.

Methodology & Data Sources

This analysis applies a mixed-methods research approach, integrating structured reviews of clinical literature, regulatory documents, and public data with targeted interviews of clinicians, supply professionals, payers, and industry experts. Data triangulation and independent analyst reviews elevate the reliability and applicability of findings for commercial and policy decisions.

Why This Report Matters

  • Enables leaders to identify strategic investment and product development opportunities based on actionable, segmented market intelligence.
  • Supports evidence-informed decisions on procurement, reimbursement, and care delivery in a rapidly evolving landscape.
  • Facilitates competitive benchmarking and partnership identification within an increasingly collaborative and data-driven market environment.

Conclusion

As bursitis care advances, organizations that integrate evidence-based approaches, agile supply chain practices, and patient-centered innovations will be positioned to deliver high-quality, sustainable solutions. Proactive collaboration and adaptive strategy are essential to capitalize on the evolving bursitis treatment market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bursitis Treatment Market, by Treatment Type
8.1. Home Care
8.1.1. Ice Therapy
8.1.2. Rest Immobilization
8.1.3. Warm Compress
8.2. Injectable Therapy
8.2.1. Corticosteroid Injections
8.2.2. Hyaluronic Acid Injections
8.2.3. Platelet-Rich Plasma Therapy
8.3. Oral Medication
8.3.1. Over-The-Counter Nonsteroidal Anti-Inflammatory Drugs
8.3.2. Prescription Nonsteroidal Anti-Inflammatory Drugs
8.4. Physical Therapy
8.4.1. Cryotherapy
8.4.2. Exercise Therapy
8.4.3. Manual Therapy
8.5. Surgical Intervention
8.5.1. Arthroscopic Surgery
8.5.2. Open Surgery
9. Bursitis Treatment Market, by Product Category
9.1. Antibiotics
9.2. Biologics
9.3. Corticosteroids
9.4. Nonsteroidal Anti-Inflammatory Drugs
10. Bursitis Treatment Market, by Application Site
10.1. Elbow
10.2. Heel
10.3. Hip
10.4. Knee
10.5. Shoulder
11. Bursitis Treatment Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Home Care Settings
11.3. Hospitals
11.4. Orthopedic Clinics
11.5. Sports Medicine Centers
12. Bursitis Treatment Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Bursitis Treatment Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Bursitis Treatment Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Bursitis Treatment Market
16. China Bursitis Treatment Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AbbVie Inc.
17.6. Amgen Inc.
17.7. Arinna Lifesciences Ltd.
17.8. AstraZeneca PLC
17.9. Bioanalytical Systems, Inc.
17.10. Bristol-Myers Squibb Company
17.11. Crescent Formulations Pvt.Ltd.
17.12. Eli Lilly and Company
17.13. F. Hoffmann-La Roche Ltd.
17.14. GlaxoSmithKline plc
17.15. Johnson & Johnson Services, Inc.
17.16. Merck & Co., Inc.
17.17. NIDEK CO., LTD.
17.18. Novartis AG
17.19. Perrigo Company PLC
17.20. Pfizer Inc.
17.21. Sanofi S.A.
17.22. Sun Pharmaceutical Industries Limited
17.23. Teva Pharmaceutical Industries Ltd.
17.24. Topcon Corporation
List of Figures
FIGURE 1. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BURSITIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BURSITIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BURSITIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BURSITIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BURSITIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ICE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ICE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ICE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REST IMMOBILIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REST IMMOBILIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REST IMMOBILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY WARM COMPRESS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY WARM COMPRESS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY WARM COMPRESS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PLATELET-RICH PLASMA THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PLATELET-RICH PLASMA THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PLATELET-RICH PLASMA THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRESCRIPTION NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRESCRIPTION NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRESCRIPTION NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY EXERCISE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY EXERCISE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MANUAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MANUAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY MANUAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ARTHROSCOPIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ARTHROSCOPIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ARTHROSCOPIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HEEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HEEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HEEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY ORTHOPEDIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SPORTS MEDICINE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SPORTS MEDICINE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY SPORTS MEDICINE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPE BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. EUROPE BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 150. EUROPE BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 154. EUROPE BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 156. EUROPE BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 157. EUROPE BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. AFRICA BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. AFRICA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 170. AFRICA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 171. AFRICA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 172. AFRICA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 173. AFRICA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 175. AFRICA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 176. AFRICA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 177. AFRICA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. ASEAN BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASEAN BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 191. ASEAN BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 192. ASEAN BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 193. ASEAN BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 194. ASEAN BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 195. ASEAN BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 196. ASEAN BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 197. ASEAN BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 198. ASEAN BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. GCC BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. GCC BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 201. GCC BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 202. GCC BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 203. GCC BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 204. GCC BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 205. GCC BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 206. GCC BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 207. GCC BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 208. GCC BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. BRICS BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. BRICS BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 221. BRICS BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 222. BRICS BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 223. BRICS BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 224. BRICS BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 225. BRICS BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 226. BRICS BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 227. BRICS BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 228. BRICS BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. G7 BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. G7 BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 231. G7 BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 232. G7 BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 233. G7 BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 234. G7 BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 235. G7 BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 236. G7 BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 237. G7 BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 238. G7 BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 239. NATO BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. NATO BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 241. NATO BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 242. NATO BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 243. NATO BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 244. NATO BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 245. NATO BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 246. NATO BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 247. NATO BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 248. NATO BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL BURSITIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES BURSITIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 257. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 258. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. CHINA BURSITIS TREATMENT MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 261. CHINA BURSITIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 262. CHINA BURSITIS TREATMENT MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 263. CHINA BURSITIS TREATMENT MARKET SIZE, BY INJECTABLE THERAPY, 2018-2032 (USD MILLION)
TABLE 264. CHINA BURSITIS TREATMENT MARKET SIZE, BY ORAL MEDICATION, 2018-2032 (USD MILLION)
TABLE 265. CHINA BURSITIS TREATMENT MARKET SIZE, BY PHYSICAL THERAPY, 2018-2032 (USD MILLION)
TABLE 266. CHINA BURSITIS TREATMENT MARKET SIZE, BY SURGICAL INTERVENTION, 2018-2032 (USD MILLION)
TABLE 267. CHINA BURSITIS TREATMENT MARKET SIZE, BY PRODUCT CATEGORY, 2018-2032 (USD MILLION)
TABLE 268. CHINA BURSITIS TREATMENT MARKET SIZE, BY APPLICATION SITE, 2018-2032 (USD MILLION)
TABLE 269. CHINA BURSITIS TREATMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Bursitis Treatment market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • Arinna Lifesciences Ltd.
  • AstraZeneca PLC
  • Bioanalytical Systems, Inc.
  • Bristol-Myers Squibb Company
  • Crescent Formulations Pvt.Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • NIDEK CO., LTD.
  • Novartis AG
  • Perrigo Company PLC
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Topcon Corporation

Table Information

Report AttributeDetails
No. of Pages197
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.73 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.15 Billion
Compound Annual Growth Rate10.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Knee Bursitis Market Report 2025 - Product Image

Knee Bursitis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Repetitive Strain Injury (RSI) Treatment Market Report 2025 - Product Image

Repetitive Strain Injury (RSI) Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Essentials of Physical Medicine and Rehabilitation. Musculoskeletal Disorders, Pain, and Rehabilitation. Edition No. 4 - Product Image

Essentials of Physical Medicine and Rehabilitation. Musculoskeletal Disorders, Pain, and Rehabilitation. Edition No. 4

  • Book
Repetitive Strain Injury (Rsi) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Repetitive Strain Injury (Rsi) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Gout Therapeutics Market - Global Forecast 2026-2032 - Product Image

Gout Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From

About the Bursitis Drug Market

The Bursitis Drug market is a segment of the Musculoskeletal Disorders Drugs market. Bursitis is a condition that causes inflammation of the bursae, which are small sacs of fluid that cushion the joints. Treatment for bursitis typically involves the use of non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. In some cases, surgery may be necessary. The Musculoskeletal Disorders Drugs market is a large and growing market, driven by an aging population and increasing prevalence of musculoskeletal disorders. The market is expected to continue to grow in the coming years, driven by the increasing prevalence of musculoskeletal disorders and the development of new treatments. Some companies in the Bursitis Drug market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.